These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8319728)

  • 41. Partial deficiency of hepatic glucose-6-phosphatase in an adult patient.
    Stamm WE; Webb DI
    Arch Intern Med; 1975 Aug; 135(8):1107-9. PubMed ID: 168824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interrelationship of glycogen storage disease and gout.
    Howell RR
    Arthritis Rheum; 1965 Oct; 8(5):780-5. PubMed ID: 5216777
    [No Abstract]   [Full Text] [Related]  

  • 43. [Renal involvement in glycogen storage disease type 1: Practical issues].
    Ben Chehida A; Bensmaïl T; Ben Rehouma F; Ben Abdelaziz R; Azzouz H; Boudabbous H; Slim Abdelmoula M; Abdelhak S; Kaabachi N; Ben Turkia H; Tebib N
    Nephrol Ther; 2015 Jul; 11(4):240-5. PubMed ID: 25957470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Focal glomerulosclerosis and proteinuria in patients with solitary kidneys.
    Gutierrez-Millet V; Nieto J; Praga M; Usera G; Martinez MA; Morales JM
    Arch Intern Med; 1986 Apr; 146(4):705-9. PubMed ID: 3963952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.
    Sun MS; Pan CJ; Shieh JJ; Ghosh A; Chen LY; Mansfield BC; Ward JM; Byrne BJ; Chou JY
    Hum Mol Genet; 2002 Sep; 11(18):2155-64. PubMed ID: 12189168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Focal segmental glomerulosclerosis: prognosis of chronic renal failure].
    Razukeviciene L; Kuzminskis V; Bumblyte IA
    Medicina (Kaunas); 2003; 39 Suppl 1():16-22. PubMed ID: 12761415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycogen storage disease in adults.
    Talente GM; Coleman RA; Alter C; Baker L; Brown BI; Cannon RA; Chen YT; Crigler JF; Ferreira P; Haworth JC; Herman GE; Issenman RM; Keating JP; Linde R; Roe TF; Senior B; Wolfsdorf JI
    Ann Intern Med; 1994 Feb; 120(3):218-26. PubMed ID: 8273986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Multiple calcium oxalate stone formation in a patient with glycogen storage disease type I (von Gierke's disease) and renal tubular acidosis type I: a case report].
    Kanematsu A; Segawa T; Kakehi Y; Takeuchi H
    Hinyokika Kiyo; 1993 Jul; 39(7):645-8. PubMed ID: 8362684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports.
    Manzia TM; Angelico R; Toti L; Cillis A; Ciano P; Orlando G; Anselmo A; Angelico M; Tisone G
    Transplant Proc; 2011 May; 43(4):1181-3. PubMed ID: 21620082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective renal plasma flow in patients with glycogen storage disease type I.
    Hahn-Ullrich H; Sciuk J; Bartenstein P; Kreysing P; Ullrich K
    Eur J Pediatr; 1993 Aug; 152(8):674-6. PubMed ID: 8404972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ischemic stroke in an adult with glycogen storage disease type I.
    Goulart JM; Yoo JY; Kirchoff-Torres KF; Delman BN; Tuhrim S
    J Clin Neurosci; 2010 Nov; 17(11):1467-9. PubMed ID: 20699197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic glycogen storage disorders: what have we learned in recent years?
    Burda P; Hochuli M
    Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy.
    Chen YT; Scheinman JI; Park HK; Coleman RA; Roe CR
    N Engl J Med; 1990 Aug; 323(9):590-3. PubMed ID: 2199830
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study.
    Melis D; Parenti G; Gatti R; Casa RD; Parini R; Riva E; Burlina AB; Dionisi Vici C; Di Rocco M; Furlan F; Torcoletti M; Papadia F; Donati A; Benigno V; Andria G
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):19-25. PubMed ID: 15963056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study.
    Melis D; Cozzolino M; Minopoli G; Balivo F; Parini R; Rigoldi M; Paci S; Dionisi-Vici C; Burlina A; Andria G; Parenti G
    J Pediatr; 2015 Apr; 166(4):1079-82. PubMed ID: 25641239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disordered intestinal function in glycogen storage disease.
    Milla PJ; Atherton DA; Leonard JV; Wolff OH; Lake BD
    J Inherit Metab Dis; 1978; 1(4):155-7. PubMed ID: 229344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type 1 glycogen storage disease and recurrent calcium nephrolithiasis.
    Simöes A; Domingos F; Fortes A; Prata MM
    Nephrol Dial Transplant; 2001 Jun; 16(6):1277-9. PubMed ID: 11390734
    [No Abstract]   [Full Text] [Related]  

  • 59. Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia).
    Kishnani PS; Faulkner E; VanCamp S; Jackson M; Brown T; Boney A; Koeberl D; Chen YT
    Vet Pathol; 2001 Jan; 38(1):83-91. PubMed ID: 11199168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.